| Year |
Citation |
Score |
| 2023 |
Romano IG, Core SB, Lee NR, Mowry C, Van Rompay KKA, Huang Y, Chackerian B, Frietze KM. A bacteriophage virus-like particle vaccine against oxycodone elicits high-titer and long-lasting antibodies that sequester drug in the blood. Vaccine. PMID 38160131 DOI: 10.1016/j.vaccine.2023.12.077 |
0.407 |
|
| 2023 |
Peabody J, Core SB, Ronsard L, Lingwood D, Peabody DS, Chackerian B. An Approach for Antigen-Agnostic Identification of Virus-Like Particle-Displayed Epitopes that Engage Specific Antibody V Gene Regions. Methods in Molecular Biology (Clifton, N.J.). 2720: 55-74. PMID 37775657 DOI: 10.1007/978-1-0716-3469-1_4 |
0.334 |
|
| 2023 |
Fowler A, Van Rompay KKA, Sampson M, Leo J, Watanabe JK, Usachenko JL, Immareddy R, Lovato DM, Schiller JT, Remaley AT, Chackerian B. A virus-like particle-based bivalent PCSK9 vaccine lowers LDL-cholesterol levels in non-human primates. Npj Vaccines. 8: 142. PMID 37770440 DOI: 10.1038/s41541-023-00743-6 |
0.397 |
|
| 2023 |
Fowler A, Van Rompay KKA, Sampson M, Leo J, Watanabe JK, Usachenko JL, Immareddy R, Lovato DM, Schiller JT, Remaley AT, Chackerian B. A Virus-like particle-based bivalent PCSK9 vaccine lowers LDL-cholesterol levels in Non-Human Primates. Biorxiv : the Preprint Server For Biology. PMID 37292981 DOI: 10.1101/2023.05.15.540560 |
0.397 |
|
| 2023 |
Wholey WY, Meyer AR, Yoda ST, Chackerian B, Zikherman J, Cheng W. Mechanisms of neutralizing antibody response probed using synthetic virus-like structures. Biorxiv : the Preprint Server For Biology. PMID 36865112 DOI: 10.1101/2023.02.20.529089 |
0.344 |
|
| 2023 |
Jelínková L, Roberts B, Ajayi DT, Peabody DS, Chackerian B. The Immunogenicity of a VLP-based Malaria Vaccine Targeting CSP in Pregnant and Neonatal Mice. Biomolecules. 13. PMID 36830571 DOI: 10.3390/biom13020202 |
0.46 |
|
| 2023 |
Fowler A, Ye C, Clarke EC, Pascale JM, Peabody DS, Bradfute SB, Frietze KM, Chackerian B. A method for mapping the linear epitopes targeted by the natural antibody response to Zika virus infection using a VLP platform technology. Virology. 579: 101-110. PMID 36623351 DOI: 10.1016/j.virol.2023.01.001 |
0.445 |
|
| 2022 |
Jelínková L, Flores-Garcia Y, Shapiro S, Roberts BT, Petrovsky N, Zavala F, Chackerian B. A vaccine targeting the L9 epitope of the malaria circumsporozoite protein confers protection from blood-stage infection in a mouse challenge model. Npj Vaccines. 7: 34. PMID 35260593 DOI: 10.1038/s41541-022-00457-1 |
0.481 |
|
| 2022 |
Webster E, Seiger KW, Core SB, Collar AL, Knapp-Broas H, Graham J, Shrestha M, Afzaal S, Geisler WM, Wheeler CM, Chackerian B, Frietze KM, Lijek RS. Immunogenicity and Protective Capacity of a Virus-like Particle Vaccine against Type 3 Secretion System Tip Protein, CT584. Vaccines. 10. PMID 35062772 DOI: 10.3390/vaccines10010111 |
0.548 |
|
| 2021 |
Ronsard L, Yousif AS, Peabody J, Okonkwo V, Devant P, Mogus AT, Barnes RM, Rohrer D, Lonberg N, Peabody D, Chackerian B, Lingwood D. Engineering an Antibody V Gene-Selective Vaccine. Frontiers in Immunology. 12: 730471. PMID 34566992 DOI: 10.3389/fimmu.2021.730471 |
0.442 |
|
| 2021 |
Fowler A, Sampson M, Remaley AT, Chackerian B. A VLP-based vaccine targeting ANGPTL3 lowers plasma triglycerides in mice. Vaccine. PMID 34474934 DOI: 10.1016/j.vaccine.2021.08.077 |
0.378 |
|
| 2021 |
Peabody DS, Peabody J, Bradfute SB, Chackerian B. RNA Phage VLP-Based Vaccine Platforms. Pharmaceuticals (Basel, Switzerland). 14. PMID 34451861 DOI: 10.3390/ph14080764 |
0.389 |
|
| 2021 |
Jelínková L, Jhun H, Eaton A, Petrovsky N, Zavala F, Chackerian B. An epitope-based malaria vaccine targeting the junctional region of circumsporozoite protein. Npj Vaccines. 6: 13. PMID 33479242 DOI: 10.1038/s41541-020-00274-4 |
0.503 |
|
| 2020 |
Mogus AT, Liu L, Jia M, Ajayi DT, Xu K, Kong R, Huang J, Yu J, Kwong PD, Mascola JR, Ho DD, Tsuji M, Chackerian B. Virus-Like Particle Based Vaccines Elicit Neutralizing Antibodies against the HIV-1 Fusion Peptide. Vaccines. 8. PMID 33333740 DOI: 10.3390/vaccines8040765 |
0.485 |
|
| 2020 |
Warner NL, Linville AC, Core SB, Moreno B, Pascale JM, Peabody DS, Chackerian B, Frietze KM. Expansion and Refinement of Deep Sequence-Coupled Biopanning Technology for Epitope-Specific Antibody Responses in Human Serum. Viruses. 12. PMID 33008118 DOI: 10.3390/v12101114 |
0.367 |
|
| 2020 |
Collar AL, Linville AC, Core SB, Wheeler CM, Geisler WM, Peabody DS, Chackerian B, Frietze KM. Antibodies to Variable Domain 4 Linear Epitopes of the Major Outer Membrane Protein Are Not Associated with Chlamydia Resolution or Reinfection in Women. Msphere. 5. PMID 32968007 DOI: 10.1128/mSphere.00654-20 |
0.433 |
|
| 2020 |
Joyner JA, Daly SM, Peabody J, Triplett KD, Pokhrel S, Elmore BO, Adebanjo D, Peabody DS, Chackerian B, Hall PR. Vaccination with VLPs Presenting a Linear Neutralizing Domain of Hla Elicits Protective Immunity. Toxins. 12. PMID 32664481 DOI: 10.3390/Toxins12070450 |
0.583 |
|
| 2020 |
Chackerian B, Peabody DS. Factors That Govern the Induction of Long-Lived Antibody Responses. Viruses. 12. PMID 31936163 DOI: 10.3390/V12010074 |
0.449 |
|
| 2020 |
Frietze KM, Core SB, Linville A, Chackerian B, Peabody DS. Assessing Antibody Specificity in Human Serum Using Deep Sequence-Coupled Biopanning. Methods in Molecular Biology (Clifton, N.J.). 2070: 157-171. PMID 31625095 DOI: 10.1007/978-1-4939-9853-1_9 |
0.367 |
|
| 2019 |
Chen Z, Wholey WY, Hassani Najafabadi A, Moon JJ, Grigorova I, Chackerian B, Cheng W. Self-Antigens Displayed on Liposomal Nanoparticles above a Threshold of Epitope Density Elicit Class-Switched Autoreactive Antibodies Independent of T Cell Help. Journal of Immunology (Baltimore, Md. : 1950). PMID 31836655 DOI: 10.4049/Jimmunol.1801677 |
0.419 |
|
| 2019 |
Sangesland M, Ronsard L, Kazer SW, Bals J, Boyoglu-Barnum S, Yousif AS, Barnes R, Feldman J, Quirindongo-Crespo M, McTamney PM, Rohrer D, Lonberg N, Chackerian B, Graham BS, Kanekiyo M, et al. Germline-Encoded Affinity for Cognate Antigen Enables Vaccine Amplification of a Human Broadly Neutralizing Response against Influenza Virus. Immunity. PMID 31563464 DOI: 10.1016/J.Immuni.2019.09.001 |
0.485 |
|
| 2019 |
Maphis NM, Peabody J, Crossey E, Jiang S, Jamaleddin Ahmad FA, Alvarez M, Mansoor SK, Yaney A, Yang Y, Sillerud LO, Wilson CM, Selwyn R, Brigman JL, Cannon JL, Peabody DS, ... Chackerian B, et al. Qß Virus-like particle-based vaccine induces robust immunity and protects against tauopathy. Npj Vaccines. 4: 2. PMID 31231552 DOI: 10.1038/s41541-019-0118-4 |
0.43 |
|
| 2019 |
Janitzek CM, Peabody J, Thrane S, H R Carlsen P, G Theander T, Salanti A, Chackerian B, A Nielsen M, Sander AF. A proof-of-concept study for the design of a VLP-based combinatorial HPV and placental malaria vaccine. Scientific Reports. 9: 5260. PMID 30918267 DOI: 10.1038/S41598-019-41522-5 |
0.565 |
|
| 2019 |
Kunda NK, Peabody J, Zhai L, Price DN, Chackerian B, Tumban E, Muttil P. Evaluation of the thermal stability and the protective efficacy of spray-dried HPV vaccine, Gardasil® 9. Human Vaccines & Immunotherapeutics. PMID 30883270 DOI: 10.1080/21645515.2019.1593727 |
0.507 |
|
| 2018 |
Frietze KM, Lijek R, Chackerian B. Applying lessons from human papillomavirus vaccines to the development of vaccines against Chlamydia trachomatis. Expert Review of Vaccines. 1-8. PMID 30300019 DOI: 10.1080/14760584.2018.1534587 |
0.578 |
|
| 2018 |
Ntumngia FB, Thomson-Luque R, Galusic S, Frato G, Frischmann S, Peabody DS, Chackerian B, Ferreira MU, King CL, Adams JH. Identification and immunological characterization of the ligand domain of Plasmodium vivax reticulocyte binding protein 1a. The Journal of Infectious Diseases. PMID 29741629 DOI: 10.1093/Infdis/Jiy273 |
0.329 |
|
| 2017 |
Zhai L, Peabody J, Pang YS, Schiller J, Chackerian B, Tumban E. A novel candidate MS2 phage VLP vaccine displaying a tandem HPV L2 peptide offers similar protection in mice to Gardasil-9. Antiviral Research. PMID 28939477 DOI: 10.1016/J.Antiviral.2017.09.012 |
0.493 |
|
| 2017 |
Peabody J, Muttil P, Chackerian B, Tumban E. Characterization of a spray-dried candidate HPV L2-VLP vaccine stored for multiple years at room temperature. Papillomavirus Research (Amsterdam, Netherlands). 3: 116-120. PMID 28720444 DOI: 10.1016/J.Pvr.2017.03.004 |
0.514 |
|
| 2017 |
Daly SM, Joyner JA, Triplett KD, Elmore BO, Pokhrel S, Frietze KM, Peabody DS, Chackerian B, Hall PR. VLP-based vaccine induces immune control of Staphylococcus aureus virulence regulation. Scientific Reports. 7: 637. PMID 28377579 DOI: 10.1038/S41598-017-00753-0 |
0.531 |
|
| 2017 |
Frietze KM, Pascale JM, Moreno B, Chackerian B, Peabody DS. Pathogen-specific deep sequence-coupled biopanning: A method for surveying human antibody responses. Plos One. 12: e0171511. PMID 28152075 DOI: 10.1371/Journal.Pone.0171511 |
0.521 |
|
| 2017 |
Lindquist IE, Crossey E, Amar M, Remaley A, Chackerian B. A VACCINE-BASED STRATEGY FOR REDUCING CARDIOVASCULAR DISEASE RISK FACTORS Journal of the American College of Cardiology. 69: 1783. DOI: 10.1016/S0735-1097(17)35172-0 |
0.308 |
|
| 2016 |
Chackerian B, Remaley A. Vaccine strategies for lowering LDL by immunization against proprotein convertase subtilisin/kexin type 9. Current Opinion in Lipidology. 27: 345-350. PMID 27389630 DOI: 10.1097/Mol.0000000000000312 |
0.47 |
|
| 2016 |
Frietze KM, Peabody DS, Chackerian B. Engineering virus-like particles as vaccine platforms. Current Opinion in Virology. 18: 44-49. PMID 27039982 DOI: 10.1016/J.Coviro.2016.03.001 |
0.546 |
|
| 2016 |
Saboo S, Tumban E, Peabody J, Wafula D, Peabody DS, Chackerian B, Muttil P. Optimized Formulation of a Thermostable Spray-Dried Virus-Like Particle Vaccine against Human Papillomavirus. Molecular Pharmaceutics. 13: 1646-55. PMID 27019231 DOI: 10.1021/Acs.Molpharmaceut.6B00072 |
0.564 |
|
| 2016 |
Chackerian B, Frietze KM. Moving towards a new class of vaccines for non-infectious chronic diseases. Expert Review of Vaccines. 15: 561-3. PMID 26919571 DOI: 10.1586/14760584.2016.1159136 |
0.416 |
|
| 2016 |
Jiang RT, Schellenbacher C, Chackerian B, Roden RB. Progress and prospects for L2-based human papillomavirus vaccines. Expert Review of Vaccines. 1-10. PMID 26901354 DOI: 10.1586/14760584.2016.1157479 |
0.486 |
|
| 2016 |
Jiang RT, Schellenbacher C, Chackerian B, Roden RBS. Progress and prospects for L2-based human papillomavirus vaccines Expert Review of Vaccines. 1-10. DOI: 10.1586/14760584.2016.1157479 |
0.392 |
|
| 2015 |
Frietze KM, Roden RB, Lee JH, Shi Y, Peabody DS, Chackerian B. Identification of anti-CA125 antibody responses in ovarian cancer patients by a novel deep sequence-coupled biopanning platform. Cancer Immunology Research. PMID 26589767 DOI: 10.1158/2326-6066.Cir-15-0165 |
0.3 |
|
| 2015 |
Caldeira J, Bustos J, Peabody J, Chackerian B, Peabody DS. Epitope-Specific Anti-hCG Vaccines on a Virus Like Particle Platform. Plos One. 10: e0141407. PMID 26516771 DOI: 10.1371/Journal.Pone.0141407 |
0.575 |
|
| 2015 |
Crossey E, Amar MJ, Sampson M, Peabody J, Schiller JT, Chackerian B, Remaley AT. A cholesterol-lowering VLP vaccine that targets PCSK9. Vaccine. PMID 26413878 DOI: 10.1016/J.Vaccine.2015.09.044 |
0.526 |
|
| 2015 |
Crossey E, Frietze K, Narum DL, Peabody DS, Chackerian B. Identification of an Immunogenic Mimic of a Conserved Epitope on the Plasmodium falciparum Blood Stage Antigen AMA1 Using Virus-Like Particle (VLP) Peptide Display. Plos One. 10: e0132560. PMID 26147502 DOI: 10.1371/Journal.Pone.0132560 |
0.438 |
|
| 2015 |
Tumban E, Muttil P, Escobar CA, Peabody J, Wafula D, Peabody DS, Chackerian B. Preclinical refinements of a broadly protective VLP-based HPV vaccine targeting the minor capsid protein, L2. Vaccine. 33: 3346-53. PMID 26003490 DOI: 10.1016/J.Vaccine.2015.05.016 |
0.572 |
|
| 2015 |
O'Rourke JP, Peabody DS, Chackerian B. Affinity selection of epitope-based vaccines using a bacteriophage virus-like particle platform. Current Opinion in Virology. 11: 76-82. PMID 25829254 DOI: 10.1016/J.Coviro.2015.03.005 |
0.602 |
|
| 2015 |
O'Rourke JP, Peabody DS, Chackerian B. Affinity selection of epitope-based vaccines using a bacteriophage virus-like particle platform Current Opinion in Virology. 11: 76-82. DOI: 10.1016/j.coviro.2015.03.005 |
0.527 |
|
| 2014 |
O'Rourke JP, Daly SM, Triplett KD, Peabody D, Chackerian B, Hall PR. Development of a mimotope vaccine targeting the Staphylococcus aureus quorum sensing pathway. Plos One. 9: e111198. PMID 25379726 DOI: 10.1371/Journal.Pone.0111198 |
0.532 |
|
| 2014 |
Ord RL, Caldeira JC, Rodriguez M, Noe A, Chackerian B, Peabody DS, Gutierrez G, Lobo CA. A malaria vaccine candidate based on an epitope of the Plasmodium falciparum RH5 protein. Malaria Journal. 13: 326. PMID 25135070 DOI: 10.1186/1475-2875-13-326 |
0.512 |
|
| 2014 |
Schiller J, Chackerian B. Why HIV virions have low numbers of envelope spikes: implications for vaccine development. Plos Pathogens. 10: e1004254. PMID 25101974 DOI: 10.1371/Journal.Ppat.1004254 |
0.467 |
|
| 2014 |
Tyler M, Tumban E, Dziduszko A, Ozbun MA, Peabody DS, Chackerian B. Immunization with a consensus epitope from human papillomavirus L2 induces antibodies that are broadly neutralizing. Vaccine. 32: 4267-74. PMID 24962748 DOI: 10.1016/J.Vaccine.2014.06.054 |
0.535 |
|
| 2014 |
Tyler M, Tumban E, Peabody DS, Chackerian B. The use of hybrid virus-like particles to enhance the immunogenicity of a broadly protective HPV vaccine. Biotechnology and Bioengineering. 111: 2398-406. PMID 24917327 DOI: 10.1002/Bit.25311 |
0.593 |
|
| 2014 |
McCarthy DP, Hunter ZN, Chackerian B, Shea LD, Miller SD. Targeted immunomodulation using antigen-conjugated nanoparticles. Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology. 6: 298-315. PMID 24616452 DOI: 10.1002/Wnan.1263 |
0.69 |
|
| 2014 |
Tyler M, Tumban E, Chackerian B. Second-generation prophylactic HPV vaccines: successes and challenges. Expert Review of Vaccines. 13: 247-55. PMID 24350614 DOI: 10.1586/14760584.2014.865523 |
0.504 |
|
| 2014 |
Van Rompay KK, Hunter Z, Jayashankar K, Peabody J, Montefiori D, LaBranche CC, Keele BF, Jensen K, Abel K, Chackerian B. A vaccine against CCR5 protects a subset of macaques upon intravaginal challenge with simian immunodeficiency virus SIVmac251. Journal of Virology. 88: 2011-24. PMID 24307581 DOI: 10.1128/Jvi.02447-13 |
0.767 |
|
| 2014 |
Schiller JT, Chackerian B. Learning from the Success of HPV Vaccines to Develop HIV Vaccines that Break B Cell Self-tolerance Aids Research and Human Retroviruses. 30: A85-A86. DOI: 10.1089/Aid.2014.5156C.Abstract |
0.552 |
|
| 2013 |
Tumban E, Peabody J, Peabody DS, Chackerian B. A universal virus-like particle-based vaccine for human papillomavirus: longevity of protection and role of endogenous and exogenous adjuvants. Vaccine. 31: 4647-54. PMID 23933337 DOI: 10.1016/J.Vaccine.2013.07.052 |
0.632 |
|
| 2012 |
Tumban E, Peabody J, Tyler M, Peabody DS, Chackerian B. VLPs displaying a single L2 epitope induce broadly cross-neutralizing antibodies against human papillomavirus. Plos One. 7: e49751. PMID 23185426 DOI: 10.1371/Journal.Pone.0049751 |
0.554 |
|
| 2012 |
Epler K, Padilla D, Phillips G, Crowder P, Castillo R, Wilkinson D, Wilkinson B, Burgard C, Kalinich R, Townson J, Chackerian B, Willman C, Peabody D, Wharton W, Brinker JC, et al. Delivery of ricin toxin A-chain by peptide-targeted mesoporous silica nanoparticle-supported lipid bilayers Advanced Healthcare Materials. 1: 348-353. PMID 23184753 DOI: 10.1002/Adhm.201200022 |
0.305 |
|
| 2012 |
Ashley CE, Carnes EC, Epler KE, Padilla DP, Phillips GK, Castillo RE, Wilkinson DC, Wilkinson BS, Burgard CA, Kalinich RM, Townson JL, Chackerian B, Willman CL, Peabody DS, Wharton W, et al. Delivery of small interfering RNA by peptide-targeted mesoporous silica nanoparticle-supported lipid bilayers. Acs Nano. 6: 2174-88. PMID 22309035 DOI: 10.1021/Nn204102Q |
0.34 |
|
| 2011 |
Cuburu N, Chackerian B. Genital delivery of virus-like particle and pseudovirus-based vaccines. Expert Review of Vaccines. 10: 1245-8. PMID 21919611 DOI: 10.1586/Erv.11.104 |
0.575 |
|
| 2011 |
Tumban E, Peabody J, Peabody DS, Chackerian B. A pan-HPV vaccine based on bacteriophage PP7 VLPs displaying broadly cross-neutralizing epitopes from the HPV minor capsid protein, L2. Plos One. 6: e23310. PMID 21858066 DOI: 10.1371/Journal.Pone.0023310 |
0.518 |
|
| 2011 |
Hunter Z, Tumban E, Dziduszko A, Chackerian B. Aerosol delivery of virus-like particles to the genital tract induces local and systemic antibody responses. Vaccine. 29: 4584-92. PMID 21549786 DOI: 10.1016/J.Vaccine.2011.04.051 |
0.754 |
|
| 2011 |
Chackerian B, Caldeira Jdo C, Peabody J, Peabody DS. Peptide epitope identification by affinity selection on bacteriophage MS2 virus-like particles. Journal of Molecular Biology. 409: 225-37. PMID 21501621 DOI: 10.1016/J.Jmb.2011.03.072 |
0.423 |
|
| 2011 |
Ashley CE, Carnes EC, Phillips GK, Padilla D, Durfee PN, Brown PA, Hanna TN, Liu J, Phillips B, Carter MB, Carroll NJ, Jiang X, Dunphy DR, Willman CL, Petsev DN, ... ... Chackerian B, et al. The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers. Nature Materials. 10: 389-97. PMID 21499315 DOI: 10.1038/Nmat2992 |
0.328 |
|
| 2010 |
Chackerian B. Virus-like particle based vaccines for Alzheimer disease. Human Vaccines. 6: 926-30. PMID 20864801 DOI: 10.4161/Hv.6.11.12655 |
0.562 |
|
| 2010 |
Caldeira Jdo C, Medford A, Kines RC, Lino CA, Schiller JT, Chackerian B, Peabody DS. Immunogenic display of diverse peptides, including a broadly cross-type neutralizing human papillomavirus L2 epitope, on virus-like particles of the RNA bacteriophage PP7. Vaccine. 28: 4384-93. PMID 20434554 DOI: 10.1016/J.Vaccine.2010.04.049 |
0.486 |
|
| 2010 |
Li QY, Gordon MN, Chackerian B, Alamed J, Ugen KE, Morgan D. Virus-like peptide vaccines against Abeta N-terminal or C-terminal domains reduce amyloid deposition in APP transgenic mice without addition of adjuvant. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 5: 133-42. PMID 20066498 DOI: 10.1007/S11481-009-9183-1 |
0.497 |
|
| 2009 |
Hunter Z, Smyth HD, Durfee P, Chackerian B. Induction of mucosal and systemic antibody responses against the HIV coreceptor CCR5 upon intramuscular immunization and aerosol delivery of a virus-like particle based vaccine. Vaccine. 28: 403-14. PMID 19849995 DOI: 10.1016/J.Vaccine.2009.10.035 |
0.767 |
|
| 2008 |
Peabody DS, Manifold-Wheeler B, Medford A, Jordan SK, do Carmo Caldeira J, Chackerian B. Immunogenic display of diverse peptides on virus-like particles of RNA phage MS2. Journal of Molecular Biology. 380: 252-63. PMID 18508079 DOI: 10.1016/J.Jmb.2008.04.049 |
0.433 |
|
| 2008 |
Chackerian B, Durfee MR, Schiller JT. Virus-like display of a neo-self antigen reverses B cell anergy in a B cell receptor transgenic mouse model. Journal of Immunology (Baltimore, Md. : 1950). 180: 5816-25. PMID 18424700 DOI: 10.4049/Jimmunol.180.9.5816 |
0.385 |
|
| 2008 |
Li Q, Gordon MN, Chackerian B, Alamed J, Ugen KE, Morgan D. P2-342: Vaccination of amyloid precursor protein transgenic mice with a bacteriophage-based short amyloid-β peptide vaccines without adjuvant induce a strong Th2-type anti-amyloid-β IgG and IgM response and reduce amyloid-β burden Alzheimer's & Dementia. 4: T473-T473. DOI: 10.1016/J.Jalz.2008.05.1419 |
0.429 |
|
| 2007 |
Chackerian B. Virus-like particles: flexible platforms for vaccine development. Expert Review of Vaccines. 6: 381-90. PMID 17542753 DOI: 10.1586/14760584.6.3.381 |
0.545 |
|
| 2006 |
Chackerian B, Rangel M, Hunter Z, Peabody DS. Virus and virus-like particle-based immunogens for Alzheimer's disease induce antibody responses against amyloid-beta without concomitant T cell responses. Vaccine. 24: 6321-31. PMID 16806604 DOI: 10.1016/J.Vaccine.2006.05.059 |
0.749 |
|
| 2004 |
Li Q, Cao C, Chackerian B, Schiller J, Gordon M, Ugen KE, Morgan D. Overcoming antigen masking of anti-amyloidbeta antibodies reveals breaking of B cell tolerance by virus-like particles in amyloidbeta immunized amyloid precursor protein transgenic mice. Bmc Neuroscience. 5: 21. PMID 15186505 DOI: 10.1186/1471-2202-5-21 |
0.496 |
|
| 2004 |
Chackerian B, Briglio L, Albert PS, Lowy DR, Schiller JT. Induction of autoantibodies to CCR5 in macaques and subsequent effects upon challenge with an R5-tropic simian/human immunodeficiency virus. Journal of Virology. 78: 4037-47. PMID 15047820 DOI: 10.1128/Jvi.78.8.4037-4047.2004 |
0.576 |
|
| 2002 |
Chackerian B, Lenz P, Lowy DR, Schiller JT. Determinants of autoantibody induction by conjugated papillomavirus virus-like particles. Journal of Immunology (Baltimore, Md. : 1950). 169: 6120-6. PMID 12444114 DOI: 10.4049/Jimmunol.169.11.6120 |
0.448 |
|
| 2001 |
Chackerian B, Lowy DR, Schiller JT. Conjugation of a self-antigen to papillomavirus-like particles allows for efficient induction of protective autoantibodies. The Journal of Clinical Investigation. 108: 415-23. PMID 11489935 DOI: 10.1172/Jci11849 |
0.506 |
|
| 1999 |
Chackerian B, Lowy DR, Schiller JT. Induction of autoantibodies to mouse CCR5 with recombinant papillomavirus particles. Proceedings of the National Academy of Sciences of the United States of America. 96: 2373-8. PMID 10051649 DOI: 10.1073/Pnas.96.5.2373 |
0.48 |
|
| 1998 |
Rudensey LM, Kimata JT, Long EM, Chackerian B, Overbaugh J. Changes in the extracellular envelope glycoprotein of variants that evolve during the course of simian immunodeficiency virus SIVMne infection affect neutralizing antibody recognition, syncytium formation, and macrophage tropism but not replication, cytopathicity, or CCR-5 coreceptor recognition Journal of Virology. 72: 209-217. PMID 9420217 DOI: 10.1128/Jvi.72.1.209-217.1998 |
0.392 |
|
| 1997 |
Chackerian B, Rudensey LM, Overbaugh J. Specific N-linked and O-linked glycosylation modifications in the envelope V1 domain of simian immunodeficiency virus variants that evolve in the host alter recognition by neutralizing antibodies Journal of Virology. 71: 7719-7727. PMID 9311856 DOI: 10.1128/Jvi.71.10.7719-7727.1997 |
0.387 |
|
| 1997 |
Chackerian B, Long EM, Luciw PA, Overbaugh J. Human immunodeficiency virus type 1 coreceptors participate in postentry stages in the virus replication cycle and function in simian immunodeficiency virus infection Journal of Virology. 71: 3932-3939. PMID 9094670 DOI: 10.1128/Jvi.71.5.3932-3939.1997 |
0.34 |
|
| 1995 |
CHACKERIAN B, HAIGWOOD NL, OVERBAUGH J. Characterization of a CD4-Expressing Macaque Cell Line That Can Detect Virus after a Single Replication Cycle and Can Be Infected by Diverse Simian Immunodeficiency Virus Isolates Virology. 213: 386-394. PMID 7491763 DOI: 10.1006/Viro.1995.0011 |
0.354 |
|
| 1994 |
Chackerian B, Morton WR, Overbaugh J. Persistence of simian immunodeficiency virus Mne variants upon transmission Journal of Virology. 68: 4080-4085. PMID 8189548 DOI: 10.1128/Jvi.68.6.4080-4085.1994 |
0.343 |
|
| Show low-probability matches. |